top of page

Clinical Value of Measurable Residual Disease Assessment

Tue, Nov 30

|

online

Thanks to the technological development, classic detection approaches like conventional flow cytometry or ASO-PCR, have evolved into next generation methodologies that have supported MRD to become a more widely used prognostic indicator and clinical decision-making tool.

Registration is closed
See other events
Clinical Value of Measurable Residual Disease Assessment
Clinical Value of Measurable Residual Disease Assessment

Time & Location

Nov 30, 2021, 11:00 AM CST

online

Share this event

bottom of page